In this issue:
- 2024 ACC Expert Consensus Decision Pathway: Treating HFrEF
- Implications of AF for GDMT in patients with HF
- Implementation science to achieve equity in HF care
- New insights in acute HF
- EOL care for patients with ESHF
- Change of restriction to riociguat (Adempas®)
- Metalyse (tenecteplase) 40 mg to be discontinued
- FDA clears AI-based algorithm to detect HF
- Heart Health Check Toolkit Therapeutic inertia
- ATAGI advice on seasonal influenza vaccines in 2024
- COVID-19 resources Conferences, workshops and CPD
Download Heart Failure Practice Review: Issue 3, with commentary by Dr Jannette Tenne